Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cellectar (CLRB)
Cellectar Biosciences (CLRB) is scaling its PDC platform to expand within the radiopharmaceutical segment, and on GURU.Markets, this promising eps n+1 growth metric demonstrates that the current value is 17.90. The business relies on technology for the targeted transport of isotopes into tumors. High demand in the underserved niche of rare hematological diseases provides the company with significant market prospects.
Ringkesan rincian data analitis cellectar.com (CLRB)
- rega saham lan konsensus proyeksi valuasi:
- rincian kapitalisasi pasar:
- rincian nilai buku perusahaan:
- indikator beban kredit lan likuiditas emiten:
Total Utang marang Modal Cellectar Biosciences|CLRB - Tanggungan utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas Cellectar Biosciences, Inc.|CLRB - Utang kumulatif perusahaan|Utang marang nilai buku Cellectar Biosciences|CLRB - Silihan lan utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Cellectar Biosciences|Rasio cepet cellectar.com
- data bathi resik lan rasio valuasi:
CLRB - Bathi pungkasan|Proyeksi bathi mangsa ngarep Cellectar Biosciences|CLRB - Kapitalisasi marang bathi|Rega marang bathi mangsa ngarep Cellectar Biosciences|CLRB - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Cellectar Biosciences|CLRB - Bathi operasional EBITDA|Bathi saben saham sajrone rolas wulan pungkasan Cellectar Biosciences|CLRB - Bathi saben siji saham sajrone 12 wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan cellectar.com|CLRB - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Cellectar Biosciences
Analisis fundamental perusahaan:Cellectar
This metric is calculated as the percentage ratio of expected net earnings per share in the next period to the current value. It measures market expectations regarding the business scaling rates and the financial stability of the issuer. The high authority of Cellectar Biosciences (CLRB) in oncology and the success of Iopofosine make the earnings per share growth forecast trend on GURU.Markets a key indicator of brand capitalization.
Analisis pesaing Cellectar Biosciences
INCY (Incyte Corp.) - Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep HUTCHMED Corp (HCM)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Nuvation Bio Inc. (NUVB)|DAWN - Prakiraan wutah bathi resik saben saham ing taun ngarep|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Monopar Therapeutics Inc. MNPR|Inhibrx - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|IMAB - Prakiraan wutah bathi resik saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Fennec|HRTX: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben siji saham kanggo taun ngarep nuvectis.com NVCT|Prakiraan wutah bathi saben saham kanggo taun ngarep CHRS|Prakiraan wutah bathi resik saben saham ing taun ngarep Corbus Pharmaceuticals Holdings, Inc. CRBP|Prakiraan wutah bathi saben saham kanggo taun ngarep CRDF (Cardiff Oncology, Inc.)|BYSI (BeyondSpring Inc) - Dinamika bathi saben saham sing diarepake ing taun ngarep|BioAtla - Prakiraan wutah bathi saben saham kanggo taun ngarep|Proyeksi tambahing bathi saben saham ing taun ngarep LIXT (lixte.com)|Citius Pharma - Prakiraan wutah bathi kanggo taun ngarep|Dinamika bathi saben saham sing diarepake ing taun ngarep BLRX (BioLineRx Ltd)|CANF: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep Aprea Therapeutics, Inc. (APRE)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Kazia Therapeutics Ltd|SLXN: Dinamika bathi saben saham sing diarepake ing taun ngarep|Prakiraan wutah bathi kanggo taun ngarep NCNA|Prakiraan wutah bathi kanggo taun ngarep Chimerix Inc. (CMRX)|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Cyclacel Pharmaceuticals Inc. CYCC|GTHX (G1 Therapeutics Inc.) - Prakiraan owah-owahan bathi resik saben saham kanggo taun ngarep|KRON: Prakiraan wutah bathi saben saham kanggo taun ngarep|Prakiraan wutah bathi resik saben saham ing taun ngarep kintara.com|ONCT: Prakiraan wutah bathi kanggo taun ngarep|Prakiraan wutah bathi saben saham kanggo taun ngarep Portage Biotech Inc
